Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study).
Stirnemann J, Serratrice J, Mann T, Louge P, Christophe C, Samii K, Pignel R, Agoritsas T, Ansari M, Cannas G, Chalandon Y, Cimasoni L, Cougoul P, Desgraz B, Gervaix A, Grosgurin O, Joffre T, Lae C, Magnan MA, Menager E, Momo Bona A, Panchard MA, Pellegrini M, Reny JL, Riu B, Sahyoun C, Boet S.
Stirnemann J, et al. Among authors: boet s.
BMJ Open. 2024 Nov 28;14(11):e084825. doi: 10.1136/bmjopen-2024-084825.
BMJ Open. 2024.
PMID: 39613437
Free PMC article.
Clinical Trial.